Delivery Order SPE2DB22D2006-SPE2DB25FW4AW
Award Date 9/5/25
Potential Completion Date 9/26/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor for a specialty medication used in the treatment of systemic lupus erythematosus. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Benlysta 200 mg/ml auto-injectors, a biologic medication used to treat systemic lupus erythematosus. This firm fixed-price delivery order carries a ceiling value of $3,248.66 and is scheduled for completion by December 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Benlysta 200 mg/mL auto-injector, a pharmaceutical product used in the treatment of systemic lupus erythematosus. This firm fixed-price delivery order, valued at $6,497.32, is set to be completed by January 6, 2026, and represents a non-competitive, competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The work will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector, with an ultimate completion date of October 16, 2025. This non-competitive, firm fixed-price delivery order represents a single purchase of this biologic medication used primarily in the treatment of systemic lupus erythematosus. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Benlysta 120 mg vials, a biologic medication used to treat systemic lupus erythematosus. This firm fixed-price delivery order carries a ceiling value of $4,162.80 and is scheduled for completion by December 5, 2025. The contract represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,987.78 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on May 13, 2025, with completion expected by June 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis, representing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Benlysta 200 mg/ml auto-injectors, with a ceiling value of $6,165.34 and a completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used primarily to treat systemic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Benlysta 200 mg/ml auto-injectors, with a ceiling value of $6,165.34 and an ultimate completion date of October 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used primarily in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/ml auto-injector units with a contract ceiling value of $6,165.34. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...